EI
JAZZ icon

Ellevest Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ellevest Inc’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-158
Closed -$23.1K – 990
2023
Q1 		$23.1K Buy
158
+113
+251% +$16.7K ﹤0.01% 816
2022
Q4 		$7.17K Buy
45
+3
+7% +$440 ﹤0.01% 1107
2022
Q3 		$6K Buy
42
+25
+147% +$3.8K ﹤0.01% 1141
2022
Q2 		$3K Hold
17
– – ﹤0.01% 1098
2022
Q1 		$3K Hold
17
– – ﹤0.01% 1134
2021
Q4 		$2K Sell
17
-58
-77% -$7.62K ﹤0.01% 1166
2021
Q3 		$10K Buy
+75
New +$11.3K ﹤0.01% 816
2021
Q2 		– Sell
-92
Closed -$15K – 1340
2021
Q1 		$15K Buy
92
+13
+16% +$2.14K ﹤0.01% 715
2020
Q4 		$13K Buy
79
+50
+172% +$7.45K ﹤0.01% 702
2020
Q3 		$4K Buy
+29
New +$3.6K ﹤0.01% 799

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Ellevest Inc's JAZZ Position: Q2 2023 in Review

Ellevest Inc sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2023, closing a stake of 158 shares — an estimated $23.1K sold.

Ellevest Inc first reported a position in JAZZ in Q3 2020 and held it in 10 quarters. The position peaked at $23.1K in Q1 2023. 471 funds tracked by Wall St. Rank hold JAZZ as of Q2 2023.

  • Ellevest Inc reported no remaining Jazz Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 158 Jazz Pharmaceuticals shares in Q2 2023, an estimated $23.1K.
  • Ellevest Inc first reported a position in Jazz Pharmaceuticals in Q3 2020 and held it in 10 quarters.
  • Ellevest Inc's Jazz Pharmaceuticals position peaked at $23.1K in Q1 2023.
  • 471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.